AirNexis Therapeutics
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $200M
Investors
- 6
About AirNexis Therapeutics
Founded in 2025 and headquartered in Palo Alto, US, AirNexis Therapeutics focuses on creating advanced biologics and small molecule therapies. Founders' history is not available.AirNexis Therapeutics specializes in developing innovative therapeutic solutions targeting unmet medical needs, especially in oncology and autoimmune disorders. Their offerings include advanced biologics and small molecule therapies, utilizing techniques like monoclonal antibody production and gene editing technologies.AirNexis Therapeutics generates revenue through direct sales and strategic partnerships with healthcare organizations. Their B2B model allows products to be integrated into treatment protocols of healthcare providers and institutions. The company aims to support regulatory activities for treating chronic obstructive pulmonary disease. Future plans include launching new products and expanding into new markets, although specific geographical targets and timelines were not disclosed.
Who invested in AirNexis Therapeutics
6 investors across 1 round
See all investors in AirNexis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 9, 2026
Amount
$200M
Investors
Questions about AirNexis Therapeutics
Who invested in AirNexis Therapeutics?
AirNexis Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AirNexis Therapeutics raised?
AirNexis Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AirNexis Therapeutics last raise money?
AirNexis Therapeutics's most recent round on record is a Series A, in Jan 2026.
What does AirNexis Therapeutics do?
Founded in 2025 and headquartered in Palo Alto, US, AirNexis Therapeutics focuses on creating advanced biologics and small molecule therapies.
Where is AirNexis Therapeutics headquartered?
AirNexis Therapeutics is headquartered in Palo Alto, US.
Which VCs invest in companies like AirNexis Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AirNexis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AirNexis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.